antibody-mediated rejection
Original Article Acute cellular rejection and antibody-mediated rejection in endomyocardial biopsy after heart transplantation: a retrospective study from a single medical center
8
Eculizumab to Treat Antibody-Mediated Rejection in a 7-Year-Old Kidney Transplant Recipient
7
Clazakizumab in late antibody mediated rejection: study protocol of a randomized controlled pilot trial
13
Current perspectives on antibody-mediated rejection after lung transplantation
7
Treatment of acute antibody-mediated rejection using Rituximab
7
Eculizumab to Treat Antibody-Mediated Rejection in a 7-Year-Old Kidney Transplant Recipient
7
Antibody mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies
14
Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
9
Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
9
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
7
The Effect of Bortezomib on Antibody Mediated Rejection after Kidney Transplantation
5
Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody mediated rejection
15
Bortezomib in late antibody mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
9
Delayed hyperacute rejection in a patient who developed <em>clostridium difficile</em> infection after ABO-incompatible kidney transplantation
5
Expression of MMP-2 and TIMP-1 in Renal Tissue of Patients with Chronic Active Antibody-mediated Renal Graft Rejection
6
Bronchus associated lymphoid tissue–resident Foxp3+ T lymphocytes prevent antibody mediated lung rejection
14
Myocardial T1 mapping: where are we now and where are we going?
9
Longitudinal immunological characterization of the first presensitized recipient of a face transplant
11
Rituximab: An emerging therapeutic agent for kidney transplantation
15
Neuropsychiatric Lupus with Antibody Mediated Striatal Encephalitis
7